SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-015204
Filing Date
2024-02-14
Accepted
2024-02-14 16:05:41
Documents
60
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q ktra-20231231.htm   iXBRL 10-Q 1631744
2 EX-31.1 ktra-ex31_1.htm EX-31.1 16642
3 EX-31.2 ktra-ex31_2.htm EX-31.2 16584
4 EX-32.1 ktra-ex32_1.htm EX-32.1 9770
  Complete submission text file 0000950170-24-015204.txt   7140201

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT ktra-20231231.xsd EX-101.SCH 1383039
62 EXTRACTED XBRL INSTANCE DOCUMENT ktra-20231231_htm.xml XML 1058965
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121 (858) 350-4364
Kintara Therapeutics, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-37823 | Film No.: 24637811
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)